Standpoint Research Upgrades Coventry Health Care (CVH) to Buy
Tweet
Share
E-mailGet Alerts CVH Hot Sheet
Price: $49.99 --0%
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Standpoint Research upgraded Coventry Health Care (NYSE: CVH) to Buy with a price target of $35.00. Upside: 20.2%; dividend yield: N/A. Fwd P/E: < 9X
The firm states, "We are basically betting here that each of these names will go back to near where they were when they were downgraded (in the next 12-18 months)."
For more ratings news on Coventry Health Care click here and for the rating history of Coventry Health Care click here.
Shares of Coventry Health Care closed at $29.32 yesterday.
The firm states, "We are basically betting here that each of these names will go back to near where they were when they were downgraded (in the next 12-18 months)."
For more ratings news on Coventry Health Care click here and for the rating history of Coventry Health Care click here.
Shares of Coventry Health Care closed at $29.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- Wells Fargo Upgrades Okta, Inc (OKTA) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Dividend, Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
